Bausch Health Companies Inc. Common Stock (BHC)
R&D Expenses
$634.00M
TTM · Period ending: · USD
BHC R&D Expenses
Latest reported$634.00Mperiod ending
Latest reported$634.00Mperiod ending
BHC TTM R&D Expenses ($0.00 → $634.00M)
TTM R&D Expenses
High-resolution chart · PNG
BHC r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 52,271,000 | |
| 52,300,000 | |
| 52,659,000 | |
| 62,021,000 | |
| 47,008,000 | |
| 39,566,000 | |
| 33,100,000 | |
| 24,800,000 | |
| 21,100,000 | |
| 18,700,000 | |
| 17,400,000 | |
| 12,100,000 | |
| 13,000,000 | |
| 11,200,000 | |
| 10,300,000 | |
| 11,900,000 | |
| 8,800,000 | |
| 8,500,000 | |
| 7,400,000 | |
| 5,800,000 | |
| 4,000,000 | |
| 2,000,000 | |
| 600,000 | |
| 600,000 | |
| 600,000 | |
| 600,000 | |
| 0 |